Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

The gross proceeds from the offering were approximately $8.0 million, prior to deducting placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the net …